Q2 2022 Holdings
Filed 2022-08-15 | 13 holdings | $84.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $42.2M | 1,198,515 | 50.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $32.5M | 771,745 | 38.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $9.1M | 24,000 | 10.8% |
| Spdr S&P Biotech ETF TR(XBI)Put | UNIT | 78464A870 | $55.7K | 750,000 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $36.2K | 716,539 | 0.0% |
| Merus N V | COM | N5749R100 | $33.4K | 1,477,109 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $28.8K | 1,167,684 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $18.1K | 971,490 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $13.0K | 1,866,652 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $7.0K | 3,736,280 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $7.0K | 214,848 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $6.0K | 861,607 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $3.9K | 5,321,231 | 0.0% |